Clinical Trial Update: Assessment of Opioid Analgesia in Sickle Cell [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing opioid analgesia in sickle cell disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: Children's National Research Institute | Conditions: Sickle Cell Disease | Phase 4 | Status: WITHDRAWN